Indonesia and Senegal to co-host 2022 Gavi COVAX AMC Summit, together with Germany

Alongside Germany (which holds the G7 presidency in 2022), Indonesia (holding the G20 presidency) and Senegal (whose President is chairing the African Union this year) will co-host the virtual “2022 Gavi COVAX AMC Summit: Break COVID Now” which takes place at 12pm CEST on Friday 8 April. The G7, G20 and African Union member countries represent the majority of the world’s population and GDP – an incredible show of global solidarity and a reminder that the COVID-19 pandemic is sadly not over, and continues to need a concerted global effort to finish the job on vaccination and to anticipate future shocks and risks.
This summit aims to meet the urgent need to raise US$ 3.8 billion to support global COVID-19 vaccination as part of a broader US$ 5.2 billion package – aimed to achieve equity in coverage through funding to help lower-income countries turn vaccines into vaccinations, and equity in access to prevent countries missing out in the future.
Prof. José Manuel Barroso, Board Chair of Gavi, the Vaccine Alliance: “We are honoured to see the presidents of the G7, G20 and AU come together to underline the continued importance of breaking COVID-19. We are thrilled that Indonesia and Senegal on behalf of the G20 and African Union have agreed to co-host our Summit with Germany and help us call for greater support for COVAX. All 3 political groupings have advocated for global effort in addressing global risks, the centrality of investing in global health security, and the need to ensure we learn the lessons of the pandemic and anticipate risks ahead of time.”

Geneva, 6 April 2022 – The governments holding the presidencies of the G7, the G20 and the African Union will co-host a summit to raise new urgent funding for global vaccination in lower-income economies, a sign of renewed international cooperation and a continued commitment to beat the pandemic. This summit aims to raise global attention to the fact that the COVID-19 pandemic is not over, and that advocacy and attention is still needed, even as we tackle other pressing global crises Indonesia and Senegal will co-host Gavi’s leader-level meeting alongside Germany, aimed at helping raise at least US$ 3.8 billion from donors as part of a wider US$ 5.2 billion package of support for lower-income countries supported by the Gavi COVAX Advance Market Commitment (Gavi COVAX AMC). This virtual event, entitled “Break COVID Now”, will take place on Friday 8 April at 12pm CEST.

With over 1.2 billion doses now shipped through the Gavi COVAX AMC to lower-income economies around the world, as part of over 1.4 billion doses provided in total to 145 countries and territories, COVAX has contributed to more equitable access to vaccines. In 2022, with the necessary funding in place, the aim is to continue to provide countries with longer-term visibility on supply, while also helping countries to plan for risk and to continue the focus on equitable access should there be sudden shocks or changes in the virus, through an innovative “Pandemic Vaccine Pool,” as well as increasing the speed and capacity to roll out doses and supporting dose donations with syringes and logistics costs.

We know that the pandemic is not over. COVAX has helped AMC economies as a whole reach an average of over 40% vaccination rates, but we need to finish the job. With a new variant appearing every four months since the pandemic was declared, and a greater likelihood of these variants spreading as long as some parts of the world are unvaccinated, we must support countries in meeting their national vaccination targets and also plan to face risks and shocks through our innovative pandemic pool.

“We are honoured to see the presidents of the G7, G20 and AU come together to underline the continued importance of breaking COVID-19,” said Prof. José Manuel Barroso, Chair of the Board of Gavi, the Vaccine Alliance. “We are thrilled that Indonesia and Senegal on behalf of the G20 and African Union have agreed to co-host our Summit with Germany and help us call for greater support for COVAX. All 3 political groupings have advocated for global effort in addressing global risks, the centrality of investing in global health security, and the need to ensure we learn the lessons of the pandemic and anticipate risks ahead of time.”

The 2022 Gavi COVAX AMC Investment Opportunity outlines the key fundraising goals of the summit: raising US$1.1 billion to pay for urgent delivery support and ancillaries and launching a US$2.7 billion Pandemic Vaccine Pool of contingent financing – so that when countries need additional doses to deal with risks and shocks such as new variants, COVAX will be ready and ahead of the curve. This US$ 3.8 billion urgent fundraising is part of a broader US$ 5.2 billion package of support for lower-income countries and territories.

Notes to editors

About COVAX

COVAX, the vaccines pillar of the Access to COVID-19 Tools (ACT) Accelerator, is co-led by CEPI, Gavi and WHO – working in partnership with developed and developing country vaccine manufacturers, UNICEF, PAHO, the World Bank, and others. It is the only global initiative that is working with governments and manufacturers to ensure COVID-19 vaccines are available worldwide to both high-income and lower-income countries.

Gavi’s role in COVAX

Gavi leads on procurement and delivery at scale for COVAX: designing and managing the COVAX Facility and the Gavi COVAX AMC and working with its traditional Alliance partners UNICEF and WHO, along with governments, on country readiness and delivery.

As part of this role, Gavi hosts the Office of the COVAX Facility to coordinate the operation and governance of the mechanism as a whole, holds financial and legal relationships with 193 Facility participants, and manages the COVAX Facility deals portfolio: negotiating advance purchase agreements with manufacturers of promising vaccine candidates to secure doses on behalf of all COVAX Facility participants. Gavi also coordinates design, operationalisation and fundraising for the Gavi COVAX AMC, the mechanism that provides access to donor-funded doses of vaccine to 92 lower-income economies. As part of this work, Gavi provides funding and oversight for UNICEF procurement and delivery of vaccines to all AMC participants – operationalising the advance purchase agreements between Gavi and manufacturers – as well as support for partners’ and governments work on readiness and delivery. This includes tailored support to governments, UNICEF, WHO and other partners for cold chain equipment, technical assistance, syringes, vehicles, and other aspects of the vastly complex logistical operation for delivery. Gavi also co-designed, raises funds for and supports the operationalisation of the AMC’s no-fault compensation mechanism as well as the COVAX Humanitarian Buffer.

About Gavi, the Vaccine Alliance

Gavi, the Vaccine Alliance is a public-private partnership that helps vaccinate half the world’s children against some of the world’s deadliest diseases. Since its inception in 2000, Gavi has helped to immunise a whole generation – over 888 million children – and prevented more than 15 million future deaths, helping to halve child mortality in 73 lower-income countries. Gavi also plays a key role in improving global health security by supporting health systems as well as funding global stockpiles for Ebola, cholera, meningitis and yellow fever vaccines. After two decades of progress, Gavi is now focused on protecting the next generation and reaching the unvaccinated children still being left behind, employing innovative finance and the latest technology – from drones to biometrics – to save millions more lives, prevent outbreaks before they can spread and help countries on the road to self-sufficiency. Learn more at www.gavi.org and connect with us on Facebook and Twitter.

Gavi is a co-convener of COVAX, the vaccines pillar of the Access to COVID-19 Tools (ACT) Accelerator, together with the Coalition for Epidemic Preparedness Innovations (CEPI) and the World Health Organization (WHO). In its role Gavi is focused on procurement and delivery for COVAX: coordinating the design, implementation and administration of the COVAX Facility and the Gavi COVAX AMC and working with its Alliance partners UNICEF and WHO, along with governments, on country readiness and delivery.

The Vaccine Alliance brings together developing country and donor governments, the World Health Organization, UNICEF, the World Bank, the vaccine industry, technical agencies, civil society, the Bill & Melinda Gates Foundation and other private sector partners. View the full list of donor governments and other leading organizations that fund Gavi’s work here.

MEDIA CONTACTS

Evan O’Connell
+41 79 682 18 95
eoconnell@gavi.org

Meg Sharafudeen
+41 79 711 55 54
msharafudeen@gavi.org

Iryna Mazur
+41 79 429 3671
imazur@gavi.org

Laura Shevlin
+ 41 79 529 92 87
lshevlin@gavi.org

Cirũ Kariũki
+41 79 913 94 41
ckariuki@gavi.org

Collins Weru Mwai
+250787836638
cmwai@gavi.org

Gavi is an international organisation bringing together public and private sectors with the shared goal of saving lives and protecting people’s health by increasing equitable and sustainable use of vaccines.

VaccinesWork is an award-winning digital platform hosted by Gavi, the Vaccine Alliance covering news, features and explainers from every corner of global health and immunisation.